C
Market Data
$14.79−$3.48 (−19.03%)
CRVS · Last trade
Prev Close
$18.26
Range (30d)
$13.15 – $17.89
Recent Filings
- 8-K495.4 KBCorvus Pharmaceuticals, Inc.Mar 13, 8:46 AM ET·0001104659-26-027390
- 10-K12.4 MBCorvus Pharmaceuticals, Inc.Mar 12, 4:05 PM ET·0001104659-26-027047
- 8-K286.2 KBCorvus Pharmaceuticals, Inc.Mar 12, 4:02 PM ET·0001171843-26-001526
- 8-K550.3 KBCorvus Pharmaceuticals, Inc.Jan 23, 6:06 AM ET·0001104659-26-005968
- 8-K192.8 KBCorvus Pharmaceuticals, Inc.Jan 20, 4:12 PM ET·0001104659-26-005035
- 8-K2.5 MBCorvus Pharmaceuticals, Inc.Jan 20, 7:13 AM ET·0001104659-26-004795
- 10-Q9.2 MBCorvus Pharmaceuticals, Inc.Nov 4, 4:03 PM ET·0001104659-25-106259
- 8-K288.3 KBCorvus Pharmaceuticals, Inc.Nov 4, 4:01 PM ET·0001171843-25-006973
- 8-K143.9 KBCorvus Pharmaceuticals, Inc.Oct 2, 4:37 PM ET·0001104659-25-096103
- 10-Q9.0 MBCorvus Pharmaceuticals, Inc.Aug 7, 4:02 PM ET·0001558370-25-010755
Insiders
10- ADAMS STREET PARTNERS LLC10% Owner
- Arcara JeffreyChief Business Officer
- Buggy Joseph JEVP Discovery Research
- CLARK IAN TDirector
- Coloma Jason VSVP, Chief Business Officer
- EcoR1 Capital, LLC10% Owner
- Gould Terry PDirector, 10% Owner
- Grais LindaDirector
- Hunt Daniel W.SVP, Chief Business Officer
- ISALY SAMUEL DDirector
Tickers
Addresses
business
901 GATEWAY BLVD, THIRD FLOOR
SOUTH SAN FRANCISCO, CA, 94080
mailing
901 GATEWAY BLVD, THIRD FLOOR
SOUTH SAN FRANCISCO, CA, 94080